2171 — CARsgen Therapeutics Holdings Balance Sheet
0.000.00%
- HK$10.49bn
- HK$9.27bn
- CNY125.66m
Annual balance sheet for CARsgen Therapeutics Holdings, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 3,007 | 2,268 | 1,850 | 1,479 | 1,123 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 49 | 16.6 | 11.8 | 32.8 | 31.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 3,071 | 2,301 | 1,873 | 1,530 | 1,178 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 386 | 441 | 361 | 124 | 97.8 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 3,506 | 2,763 | 2,257 | 1,673 | 1,292 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 389 | 171 | 196 | 254 | 205 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 509 | 290 | 456 | 616 | 509 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 2,997 | 2,473 | 1,802 | 1,057 | 783 |
| Total Liabilities & Shareholders' Equity | 3,506 | 2,763 | 2,257 | 1,673 | 1,292 |
| Total Common Shares Outstanding |